Intralesional Injection of Acyclovir Versus Candida Antigen in Treatment of Plantar Warts
Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the efficacy of intralesional injection of acyclovir versus
candida antigen in plantar wart patients will be randomly divided into 2 groups,At least 20
patients will be enrolled in each group.
Group 1: will be treated with intralesional injection of acyclovir 250 mg acyclovir vial
diluted with 3.5 ml saline to get approximately 70 mg/ml solution. The base of each wart was
injected with 0.1 ml of intralesional acyclovir (70 mg/ml) every 2 weeks until the resolution
of warts or for a maximum of 5 sessions Group 2: will be treated by intralesional Candida
antigen injection (candida antigen ) at a dose of 0.2 mL. injected into the largest wart
every 2 weeks until complete clearance of warts or for a maximum of 5 treatment sessions.
3.Patient evaluation: Assessment of treatment efficacy and side effects will be carried out
by clinical examination and comparative photographic evaluation and dermoscopy